Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Affymetrix and Institut Curie team up on cancer project

This article was originally published in Clinica

Executive Summary

Affymetrix has joined forces with Paris, France-based Institut Curie to find genetic signatures for cancer that could be used to develop diagnostic tests. Affymetrix' GeneChip will be used in large-scale clinical studies to analyse the DNA sequence and gene expression for tumour samples that have been collected using Institut Curie's "snap-frozen" sampling method. According to Affymetrix, Institut Curie's method produces "exceptional quality" samples that should, in turn, produce more accurate and reliable diagnostics.

Topics

UsernamePublicRestriction

Register

MT054289

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel